home / stock / amrx / amrx articles
Friday, Amneal Pharmaceuticals Inc (NASDAQ:AMRX) announced a significant agreement valued at over $270 million to settle claims related t...
Friday, Amneal Pharmaceuticals Inc (NASDAQ:AMRX) reported fourth-quarter 2023 revenues of $616.98 million, up 1% Y/Y, missing the co...
PHILADELPHIA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Amneal Pharmaceuticals, Inc. (NYSE:AMRX) ("Am...
U.S. stocks traded higher Tuesday, with the Nasdaq Composite gaining over 100 points. Here are some big stocks recording gains in the trading sessi...
U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Friday. Here are some big stocks recording gains in Friday's s...
News, Short Squeeze, Breakout and More Instantly...
Amneal Pharmaceuticals Inc. Class A Company Name:
AMRX Stock Symbol:
NYSE Market:
Fourth ESG Report Details Company’s Progress Towards Environmental Sustainability and Contributions Toward Building Healthier Communities as a Leading Provider of Accessible Medicines Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Companyȁ...
The Company’s leading R&D capabilities and robust, expanded manufacturing capacity are helping to address chronic market shortages Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the continued expansion of it...
Significantly expanding access to affordable, life-saving opioid overdose rescue medicine Entered distribution agreement with California; actively engaging with other states and municipalities to expand access Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” o...